RT Journal Article SR Electronic(1) A1 Rathnayake, Dulaanga A1 M. M., Basith A1 E., Tharmini A1 M., Umakanth A1 K. T., Sundaresan A1 Jayasekara, P. I. A1 Sigera, L. S. M. A1 Welagedara, P. G. R. I. S. A1 Francis, VaithehiYR 2021 T1 A rare case of Escherichia coli and Rhizopus sinusitis complicated with pneumocephalus, E. coli psoas abscess and sepsis JF Access Microbiology, VO 3 IS 7 OP SP 000243 DO https://doi.org/10.1099/acmi.0.000243 PB Microbiology Society, SN 2516-8290, AB Sinusitis is a common ailment a clinician comes across in their day-to-day practice. Simple as it may sound, it may become a very debilitating condition depending on the comorbidities of the patient and the organism involved. Rhizopus and Escherichia coli are less common organisms to affect the sinuses, but they are more common in immunocompromised patients such as patients with uncontrolled diabetes. Rhizopus can be a very debilitating infection as it erodes into the bone and blood vessels resulting in tissue necrosis. However, coinfection of both of these organisms is a very rare occurrence. Psoas abscess is also a less common infection in the immunocompetent patients but it is more common among the immunocompromised patients. It is extremely rare for both of these organisms to cause sinusitis in one patient, and for E. coli to simultaneously infect two different sites in the same patient. We report a case where a diabetic patient who had E. coli and Rhizopus coinfected sinusitis with simultaneous E. coli psoas abscess was successfully managed. The Rhizopus was treated with liposomal amphotericin B for 16 weeks while E. coli was treated with IV Meropenum. Furthermore, pneumocephalus is a condition that usually occurs following head trauma but the patient we are reporting developed pneumocephalus following Rhizopus sinusitis, which was treated with high-flow oxygen., UL https://www.microbiologyresearch.org/content/journal/acmi/10.1099/acmi.0.000243